AscellaHealth Forecasts Robust Outlook for Specialty Pharmacy Industry in 2024

AscellaHealth predicts robust growth in the specialty pharmacy industry in 2024, driven by new FDA-approved medications and potentially life-saving cell and gene therapies. The company is well-positioned to support stakeholders such as patients, life sciences, and biotechnology manufacturers, payers, and providers. AscellaHealth emphasizes patient-centric care and innovative solutions for specialty drugs, rare diseases, and complex conditions.